Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Beckman CEO Resigns As Company Faces Regulatory Challenges

This article was originally published in The Gray Sheet

Executive Summary

Beckman Coulter announced the resignation of Scott Garrett as chairman, president and CEO Sept. 7 as the firm tries to recover from a recent FDA-triggered diagnostic test market withdrawal and ongoing regulatory scrutiny

You may also be interested in...



People In Brief

Cook Group founder dies, son takes helm

People In Brief

Cook Group founder dies, son takes helm

Danaher Buys Beckman: Fixing Quality Issues, Cutting Costs Are Priorities

Danaher’s priorities for its newly acquired Beckman Coulter diagnostics business will include cutting $250 million in costs, completing quality control fixes already underway and getting certain cardiac troponin assays back on the market.

Related Content

Topics

UsernamePublicRestriction

Register

MT029358

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel